SCHEMBL4060758

SCHEMBL4060758

CCCn1c(=O)n(C)c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccncc4)cc3)cc21

nearest known ligand 0.65

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 18/20 0.65
ADORA1 P30542 11/20 0.65
ADORA3 P0DMS8 10/20 0.65
ADORA2A P29274 7/20 0.51
LMNA P02545 2/20 0.50
HTT P42858 2/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4059617 0.93 ADORA2B (0.75) ADORA2BADORA1ADORA3ADORA2ALMNA
SCHEMBL4053029 0.91 ADORA2B (0.58) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4053837 0.90 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2ALMNA
SCHEMBL4054039 0.90 ADORA2B (0.64) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4052706 0.86 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2ALMNA
SCHEMBL4062364 0.86 ADORA2B (0.61) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4050752 0.85 ADORA2B (0.88) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4057341 0.83 ADORA2B (0.57) ADORA2BADORA1ADORA3ADORA2ALMNA
SCHEMBL4051673 0.83 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4712380 0.83 ADORA2B (0.57) ADORA2BADORA1ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504398-B2 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation LABORATORIOS ALMIRALL S.A. (ES) 2009-03-17 US disclosed
EP-1492793-B1 NEW-4-(PYRROLOPYRIMIDIN-6-YL)BENZENESULPHONAMIDE DERIVATIVES ALMIRALL LAB (ES) 2008-01-16 EP disclosed